Table 4. Aligning process evaluation aims with methods, outcomes and analysis integration. Primary Aims Assessment method Outcome Analysis integration Usage Recording of consultations† MAPPIN’SDM scores† Comparison between themes identified in patient & Patient & clinician^ Themes identified in patient clinician frameworks interviews & clinician analysis Examination of themes (patient and clinician frameworks) frameworks identified within high & low MAPPIN’SDM dyad scorers† Acceptability Patient & clinician^ Themes identified in patient Comparison between themes identified in patient & interviews & clinician analysis clinician frameworks frameworks Usefulness Patient & clinician^ Themes identified in patient Comparison between themes identified in patient & interviews & clinician analysis clinician frameworks Patient CollaboRATE frameworks Association between CollaboRATE & MAPPIN’SDM questionnaire CollaboRATE scores scores†. Recording of consultations† MAPPIN’SDM scores† Examination of themes (patient and clinician frameworks) identified within high & low MAPPIN’SDM dyad scorers† Facilitators & Patient & clinician^ Themes identified in patient Comparison between themes identified in patient & barriers to interviews & clinician analysis clinician frameworks implementation frameworks Examination of themes (patient and clinician frameworks) identified within high & low MAPPIN’SDM dyad scorers† Secondary Aims Shared decision Patient CollaboRATE CollaboRATE scores Association between CollaboRATE & MAPPIN’SDM making across questionnaire MAPPIN’SDM scores† scores†. trial arms Recording of consultations† Comparison between CollaboRATE scores of intervention arm & control arm Information Patient interviews, patient Information from interviews, Descriptive comparison between control arm and trial provision across information questionnaire information provision arm trial arms & CRF questionnaire & CRF Recordings of Information from recorded consultations† consultations † chemotherapy DESI only † ^ clinician interviews in the intervention arm only Table 5: Timetable for process evaluation
Table 4. Aligning process evaluation aims with methods, outcomes and analysis integration. Primary Aims Assessment method Outcome Analysis integration Usage Recording of consultations† Patient & clinician^ interviews MAPPIN’SDM scores† Themes identified in patient & clinician analysis frameworks Comparison between themes identified in patient & clinician frameworks Examination of themes (patient and clinician frameworks) identified within high & low MAPPIN’SDM dyad scorers† Acceptability Patient & clinician^ interviews Themes identified in patient & clinician analysis frameworks Comparison between themes identified in patient & clinician frameworks Usefulness Patient & clinician^ interviews Patient CollaboRATE questionnaire Recording of consultations† Themes identified in patient & clinician analysis frameworks CollaboRATE scores MAPPIN’SDM scores† Comparison between themes identified in patient & clinician frameworks Association between CollaboRATE & MAPPIN’SDM scores†. Examination of themes (patient and clinician frameworks) identified within high & low MAPPIN’SDM dyad scorers† Facilitators & barriers to implementation Patient & clinician^ interviews Themes identified in patient & clinician analysis frameworks Comparison between themes identified in patient & clinician frameworks Examination of themes (patient and clinician frameworks) identified within high & low MAPPIN’SDM dyad scorers† Secondary Aims Shared decision making across trial arms Patient CollaboRATE questionnaire Recording of consultations† CollaboRATE scores MAPPIN’SDM scores† Association between CollaboRATE & MAPPIN’SDM scores†. Comparison between CollaboRATE scores of intervention arm & control arm Information provision across trial arms Patient interviews, patient information questionnaire & CRF Recordings of consultations† Information from interviews, information provision questionnaire & CRF Information from recorded consultations † Descriptive comparison between control arm and trial arm † chemotherapy DESI only ^ clinician interviews in the intervention arm only Table 5: Timetable for process evaluation
Age_Gap_Supplemental_Protocol_Version_3_9th_March_2016.docx